Meclisafe 50mg/5mg Tablet SR
Marketer
Pfleger Healthcare Pvt Ltd
Salt Composition
Meclizine (50mg) + Folic Acid (5mg)
Overview Meclisafe 50mg/5mg Tablet SR
Vertigo treatment utilizes the combination drug, Meclisafe 50mg/5mg SR tablets. This medication alleviates vertigo symptoms such as nausea, vomiting, and dizziness. Dosage and treatment duration for Meclisafe 50mg/5mg SR tablets should follow your physician's instructions; the prescribed amount depends on individual response and condition severity. Complete the prescribed course; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common, typically mild and transient, side effects include vomiting, dry mouth, headache, and tiredness. Persistent side effects warrant medical attention. Due to potential drowsiness and sleepiness, avoid driving or activities requiring concentration until the effects are known. Alcohol consumption should be avoided while using this medicine to prevent increased sleepiness.
Uses of Meclisafe 50mg/5mg Tablet SR
Dizziness
Major Benefits of Meclisafe 50mg/5mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meclisafe 50mg/5mg Sustained-Release Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Meclisafe 50mg/5mg Tablet SR:
- Vomiting
- Dryness in mouth
- Headache
- Fatigue
- Drowsiness
- Allergic reaction
How to use Meclisafe 50mg/5mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meclisafe 50mg/5mg Extended-Release Tablets can be administered with or without food, though consistent timing is recommended.
How Meclisafe 50mg/5mg Tablet SR works:
Each Meclisafe 50mg/5mg sustained-release tablet contains meclizine and folic acid.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Meclisafe 50mg/5mg Tablet SR concurrently with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The extended-release Meclisafe 50mg/5mg tablet is typically regarded as safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Meclisafe 50mg/5mg Tablet SR during breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, higher dosages or extended treatment with Meclisafe 50mg/5mg Tablet SR could potentially lead to drowsiness or other adverse reactions in the baby.
DrivingUNSAFE
Taking Meclisafe 50mg/5mg SR tablets might cause drowsiness, blurred vision, or dizziness. Driving is discouraged if you experience these effects.
KidneySAFE IF PRESCRIBED
The use of Meclisafe 50mg/5mg Tablet SR in individuals with impaired kidney function appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Use of Meclisafe 50mg/5mg SR tablets in patients with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Meclisafe 50mg/5mg Tablet SR :
NA
Facts to Know About Meclisafe 50mg/5mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience (CNS) |
3,018 People bought this recently